GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Medios AG (LTS:0QB4) » Definitions » Loans Receivable

Medios AG (LTS:0QB4) Loans Receivable : €0 Mil (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Medios AG Loans Receivable?

Medios AG's Loans Receivable for the quarter that ended in Mar. 2024 was €0 Mil.


Medios AG Loans Receivable Historical Data

The historical data trend for Medios AG's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medios AG Loans Receivable Chart

Medios AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medios AG Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medios AG Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Medios AG Loans Receivable Related Terms

Thank you for viewing the detailed overview of Medios AG's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Medios AG (LTS:0QB4) Business Description

Address
Friedrichstrasse 113a, Berlin, DEU, 10117
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes provision of medicinal products which focuses on pharmaceutical medicinal products; Patient-specific therapies comprise the manufacture of medications.

Medios AG (LTS:0QB4) Headlines

No Headlines